Search results
Results from the WOW.Com Content Network
The Moderna COVID‑19 vaccine, sold under the brand name Spikevax, is a COVID-19 vaccine developed by the American company Moderna, the United States National Institute of Allergy and Infectious Diseases (NIAID), and the Biomedical Advanced Research and Development Authority (BARDA).
A child is considered fully immunized two weeks after they finish the final dose of the primary series, so in most cases it'll take six weeks with Moderna, compared to 13 weeks with Pfizer.
One dose of Pfizer or Moderna vaccines appears at least 80% effective against symptomatic COVID-19. For AstraZeneca, one-shot efficacy is 70%. ... One dose of Pfizer or Moderna vaccines appears at ...
The two vaccines available since December — Pfizer and Moderna — were 90% effective after two doses, the Centers for Disease Control and Prevention reported Monday.
National regulatory authorities have granted full or emergency use authorizations for 40 COVID-19 vaccines.. Ten vaccines have been approved for emergency or full use by at least one stringent regulatory authority recognized by the World Health Organization (WHO): Pfizer–BioNTech, Oxford–AstraZeneca, Sinopharm BIBP, Moderna, Janssen, CoronaVac, Covaxin, Novavax, Convidecia, and Sanofi ...
This photo provided by Pfizer in August 2024 shows a packaging for the company's updated COVID vaccine for ages 12 and up, approved by the U.S. Food and Drug Administration on Thursday, Aug. 22, 2024.
Pfizer said Tuesday that its experimental COVID-19 pill appears effective against the omicron variant. The company also said full results of its 2,250-person study confirmed the pill's promising ...
The Pfizer–BioNTech COVID-19 vaccine, sold under the brand name Comirnaty, [2] [33] is an mRNA-based COVID-19 vaccine developed by the German biotechnology company BioNTech. For its development, BioNTech collaborated with the American company Pfizer to carry out clinical trials , logistics, and manufacturing.